ICD-10 Coding for Benzodiazepine Withdrawal(F10.23, F10.232D, F11.23)
Comprehensive guide on ICD-10 coding for benzodiazepine withdrawal, including documentation requirements and common pitfalls.
Complete code families applicable to Benzodiazepine Withdrawal
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F13.232 | Sedative, hypnotic, or anxiolytic withdrawal with perceptual disturbance | Use when withdrawal symptoms include perceptual disturbances. |
|
| F13.239 | Sedative, hypnotic, or anxiolytic withdrawal, unspecified | Use when withdrawal symptoms are present but no specific complications are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBenzodiazepine Withdrawal
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Benzodiazepine Withdrawal.
Vague documentation of withdrawal symptoms
Impact
Clinical: Potential misdiagnosis and inappropriate treatment, Regulatory: Non-compliance with documentation standards, Financial: Denied claims due to insufficient documentation
Mitigation
Use structured templates, Train staff on documentation standards
Using F13.930 instead of F13.23- for active withdrawal
Impact
Reimbursement: Incorrect DRG assignment leading to potential underpayment, Compliance: Non-compliance with coding standards, Data Quality: Inaccurate clinical data affecting patient records
Mitigation
Ensure documentation specifies withdrawal symptoms and substance.
Substance Use Documentation
Impact
Inadequate documentation of substance use history
Mitigation
Implement comprehensive intake assessments